Page last updated: 2024-10-29

ketamine and Hypokalemia

ketamine has been researched along with Hypokalemia in 1 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Hypokalemia: Abnormally low potassium concentration in the blood. It may result from potassium loss by renal secretion or by the gastrointestinal route, as by vomiting or diarrhea. It may be manifested clinically by neuromuscular disorders ranging from weakness to paralysis, by electrocardiographic abnormalities (depression of the T wave and elevation of the U wave), by renal disease, and by gastrointestinal disorders. (Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belov, VA1
Vasil'ev, VI1
Gerasimov, GM1
Vishnevskaia, IG1

Other Studies

1 other study available for ketamine and Hypokalemia

ArticleYear
[Renin activity and functional status of the adrenal cortex in surgical intervention during ketamine anesthesia].
    Vestnik khirurgii imeni I. I. Grekova, 1979, Volume: 122, Issue:2

    Topics: 11-Hydroxycorticosteroids; Adolescent; Adrenal Cortex; Adrenal Cortex Hormones; Adult; Aged; Aldoste

1979